Sun Pharma: Bajaj Broking recommends 'Buy'; flags 4 positive cues on charts
NiveshIQ
NSE: SUNPHARMA · Pharma
Sun Pharmaceutical Industries Ltd.
₹1,989.90▲ ₹13.20 (+0.67%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on SUNPHARMA. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Limited is a leading generic pharmaceutical company with a diverse portfolio of branded and generic formulations, and active pharmaceutical ingredients (APIs). The company generates significant revenue from various therapeutic areas, including neuropsychiatry, cardiology, and gastroenterology. Its recent acquisition of Innovcare Lifesciences for ₹271 crore is expected to expand its nutraceutical portfolio in India. Sun Pharma has a strong presence in the US and international markets, with a significant share of its revenue coming from exports. The company has been recognized for its sustainability efforts, being included in the 2026 S&P Dow Jones Best-in-Class World Index. With a strong revenue base of ₹58,462 crore and a net income of ₹11,479 crore, Sun Pharm
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹48,497 Cr +10.50% | ₹52,578 Cr +8.40% | ₹58,462 Cr +11.20% |
| EBITDA Margin | 26.85% | 29.05% | 33.70% |
| Net Profit | ₹9,611 Cr +12.90% | ₹10,965 Cr +14.10% | ₹12,872 Cr +17.40% |
| EPS | ₹39.91 | ₹45.55 | ₹47.80 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Sun Pharmaceutical Industries Limited Revenue Breakdown – NSE:SUNPHARMA
Sun Pharma Clears Key Milestone as Organon Shareholders Back USD 11.75 Billion Buyout
🔒
+ 3 more stories about Sun Pharmaceutical Industries Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹14, 612 Cr, PAT ₹2, 710 Cr, EPS ₹11.31, EBITDA margin 30.2%. Growth context: revenue YoY +12.8%, PAT YoY +25.8%, revenue QoQ -5.9%, PAT QoQ -19.8%. Street verdict: beat, revenue surprise +0.6%, PAT surprise +6.0%.
Management's focus on order wins, deal pipeline, and R&D investments is expected to drive the next leg of growth, with e...
FY26 (last completed FY): revenue ₹58, 462 Cr, PAT ₹12, 872 Cr, EBITDA margin 33.7%, EPS ₹47.80. Year-on-year: revenue Y...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for SUNPHARMA
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track SUNPHARMA alongside your other holdings
Unlock full SUNPHARMA research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Sun Pharmaceutical Industries Ltd.?
NiveshIQ detects active intelligence signals for Sun Pharmaceutical Industries Ltd. (SUNPHARMA) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Sun Pharmaceutical Industries Ltd.?
Sun Pharmaceutical Industries Ltd. operates in the Pharma sector with a market capitalisation of ₹44,697,208.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.